A prospective study on the effects of depot medroxyprogesterone acetate on trabecular and cortical bone after attainment of peak bone mass

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 107, Issue 7, 2000, Pages 863-869

  Merki Feld, Gabriele S ^a   Neff, Maurus ^b   Keller, Paul J ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Osteoporosis Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; MEDROXYPROGESTERONE ACETATE;

ACCURACY; ADULT; ARTICLE; BONE MASS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORTICAL BONE; FAMILY PLANNING; FEMALE; HUMAN; HUMAN TISSUE; LONGITUDINAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRABECULAR BONE;

ADULT; BONE DENSITY; CALCIUM; CONTRACEPTIVE AGENTS, FEMALE; ESTRADIOL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MEDROXYPROGESTERONE 17-ACETATE; MENARCHE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIUS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034046797     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2000.tb11084.x     Document Type: Article

References (41)

1. Kaunitz AM. Injectable depot medroxyprogesterone acetate contraception: an update for US clinicians. Int J Fertil Womens Med 1998; 43: 73–83.
2. Kaunitz AM, Rosenfield A. Injectable contraception with depot medroxyprogesterone acetate. Current status. Drugs 1993; 45: 857–865.
3. Jeppson S, Gershagen S, Johansson EDB, Rannevik G. Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depot-MPA as a contraceptive agent. Acta Endocrinol 1982; 99: 339–343.
4. Virutamasen P, Wangsuphachart S, Reinprayoon D, Kriengsinyot R, Leepipatpaiboon S, Gua C. Trabecular bone in long-term depot-medroxyprogesterone acetate users. Asia Oceania J Obstet Cynecol 1994; 20: 69–274.
5. Naessen T, Olsson SE, Gudmundson J. Differential effects on bone density of progestogen-only methods for contraception in premenopausal women. Contraception 1995; 52: 35–39.
6. Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr 1996; 129: 671–676.
7. Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR. Bone density in women receiving depot medroxyprogesterone acetate for contraception. BMJ 1991; 303: 13–16.
8. Melton LJ. How many women have osteoporosis now J Bone Miner Res 1995; 10: 175–177.
9. Nilas L, Gotfredsen A, Hadberg A, Christiansen C. Age-related bone loss in women evaluated by the single and dual photon technique. Bone Miner 1988; 4: 95–103.
10. Baran D, Sorensen A, Grimes J et al. Dietary modification with dairy products for preventing vertebral bone loss in premenopausal women: a three-year prospective study. J Clin Endocrinol Metab 1990; 70:264–270.
11. Kroger H, Heikkinen J, Laitinen K, Kotaniemi A. Dual-energy X-ray absorptiometry in normal women: a cross-sectional study of 717 Finnish volunteers. Osteoporos Int 1992; 2: 135–140.
12. Recker RR, Davies KM, Hinders SM, Heaney RP, Stegman MR, Kimmel DB. Bone gain in young adult women. JAMA 1992; 268: 2403–2408.
13. Riis BJ. Premenopausal bone loss: fact or artifact Osteoporos Int 1994; 4 (Suppl 1): 35–37.
14. Sowers MR, Clark MK, Hollis B, Wallace RB, Jannausch M. Radial bone mineral density in pre- and perimenopausal women: a prospective study of rates and risk factors for loss. J Bone Miner Res 1992; 7: 647–657.
15. Theintz G, Buchs B, Rizzoli R et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992; 75: 1060–1065.
16. Haapasalo H, Kannus P, Sievanen H et al. Development of mass, density, and estimated mechanical characteristics of bones in caucasian females. J Bone Miner Res 1996; 11: 1751–1760.
17. Ruegsegger P, Durand EP, Dambacher MA. Differential effects of aging and disease on trabecular and compact bone density of the radius. Bone 1991; 12: 99–105.
18. Grampp S, Majumdar S, Jergas M, Newitt D, Lang P, Genant HK. Distal radius: In vivo Assessment with quantitative MR imaging, peripheral quantitative CT, and dual X-ray absorptiometry. Radiology 1998; 198: 213–218.
19. Buchanan JR, Myers C, Lloyd T, Greer RB. Early vertebral trabecular bone loss in normal premenopausal women. J Bone Miner Res 1988; 3: 583–587.
20. Rodin A, Murby B, Smith MA et al. Premenopausal bone loss in the lumbar spine and neck of femur: a study of 225 Caucasian women. Bone 1990; 11: 1–5.
21. Arlot ME, Sornay-Rendu E, Garnero P, Vey-Marty B, Delmas PD. Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: the OFELY cohort. J Bone Miner Res 1997; 12:683–690.
22. Willing M, Sowers M, Aron D et al. Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 1998; 13: 695–705.
23. Ferrari S, Rizzoli R, Slosman D, Bonjour JP. Familial resemblance for bone mineral mass is expressed before puberty. J Clin Endocrinol Metab 1998; 83: 358–361.
24. Salamone LM, Glynn NW, Black DM et al. Determinants of premenopausal bone mineral density: the interplay of genetic and lifestyle factors. J Bone Miner Res 1996; 11: 1557–1565.
25. Ralston SH. What determines peak bone mass and bone loss Baillieres Clin Rheumatol 1997; 11: 479–494.
26. Ferrari S, Rizzoli R, Bonjour JP. Heritable and nutritional influences on bone mineral mass. Aging Clin Exp Res 1998; 10: 205–213.
27. Smith EL, Gilligan C, Smith PE, Sempos CT. Calcium supplementation and bone loss in middle-aged women. Am J Clin Nutr 1989; 50: 833–842.
28. Baran D, Sorensen A, Grimes J et al. Dietary modification with dairy products for preventing vertebral bone loss in premenopausal women: a three-year prospective study. J Clin Endocrinol Metab 1990; 70: 264–270.
29. Prior JC, Vigna YM, Barr SI, Rexworthy C, Lentle BC. Cyclic medroxyprogestcrone treatment increases bone density: a controlled trial in active women with menstrual cycle disturbances. Am J Med 1994; 96: 521–530.
30. Rico H, Revilla M, Villa LF, Alvarez-de-Buergo M, Arribas I. Longitudinal study of the effect of calcium pidolate on bone mass in eugonadal women. Calcif Tissue Int 1994; 54: 477–480.
31. Welten DC, Kemper HC, Post GB, Van-Staveren WA. A meta-analysis of the effect of calcium intake on bone mass in young and middle aged females and males. J Nutr 1995; 125: 2802–2813.
32. Ho SC, Wong E, Chan SG, Lau J, Chan C, Leung PC. Determinants of peak bone mass in Chinese women aged 21–40 years. III. Physical activity and bone mineral density. J Bone Miner Res 1997; 12: 1262–1271.
33. Kirchengast S, Gruber D, Sator M, Huber J. Interactions between somatometric parameters and endogenous hormone levels as well as hormonal induced events in females. Anthropol Anz 1998; 56: 251–265.
34. Law MR, Hackshaw AK. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ 1997; 315: 841–846.
35. Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K. Bone mineral density during long-term treatment with Norplant implants and depot medroxyprogesterone acetate. A cross- sectional study of Thai women. Contraception 1997; 56: 153–155.
36. Gbolade B, Ellis S, Murby B, Randall S, Kirkman R. Bone density in long term users of depot medroxyprogesterone acetate. Br J Obstet Gynaecol 1998; 105: 790–794.
37. Scholes D, Lacroix AZ, Ott SM, Ichikawa LE, Barlow WE. Bone mineral density in women using depot medroxyprogesterone acetate for contraception. Obstet Gynecol 1999; 93: 233–238.
38. Bahamondes L, Perrotti M, Castro S, Faundes D, Petta C, Bedone A. Forearm bone density in users of Depo-Provera as a contraceptive method. Fertil Steril 1999; 71: 849–852.
39. Cundy T, Cornish J, Roberts H, Elder H, Reid IR. Spinal bone density in women using depot medroxyprogesterone contraception. Obstet Gynecol 1998; 92:569–573.
40. Paiva LC, Pinto-Nedo AM, Faundes A. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive. Contraception 1998; 58: 351–355.
41. DeChemey A. Bone-sparing properties of oral contraceptives. Am J Obstet Gynecol 1996; 174: 15–20.